Exploratory Clinical Study of HRS-4642 Combined With Adebelimab in the Treatment of Advanced Pancreatic Cancer

NCT06427239 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: HRS-4642
DRUG: Adebrelimab

Sponsor

Fudan University

Collaborators

[object Object]